You are subscribed to the Ophthalmology Times Europe Issue Alert.
eNewsletter Subscribe
Digital subscribe banners
Print subscribe Banners
Mobile APP
June 22, 2015
Web Version | Share with a colleague | View Digital Edition
CHECK OUT OUR JUNE ISSUE
IOL design is a key factor behind the observed rates of anterior capsule opacification in this particular study. Find out why
A novel approach broadens therapeutic options in proliferative diabetic retinopathy. » What are the options?
Dr. Angelo P. Tanna explores options for glaucoma patients who do not show satisfactory response. » Consider two therapeutic choice factors
IN CASE YOU MISSED IT
Downloads
Editorial Questions? Contact the Editorial Team. Click Here. Sales, Reprints, Classified questions? Contact the Sales Team. Click Here.
UBM MEDICA
